Takbo Group Holdings Limited (8436.HK)
HKD 0.18
(-1.1%)
HKD 0.18
(-1.1%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -175.44 Million HKD | -4.23% |
| 2022 | -168.32 Million HKD | -34.91% |
| 2021 | -124.76 Million HKD | -24.37% |
| 2020 | -100.31 Million HKD | -3.83% |
| 2019 | -96.6 Million HKD | 6.77% |
| 2018 | -103.62 Million HKD | -7.48% |
| 2017 | -96.41 Million HKD | -182.78% |
| 2016 | -34.09 Million HKD | -3413.31% |
| 2015 | 1.02 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -170.38 Million HKD | 2.88% |
| 2024 Q2 | -159.99 Million HKD | 6.1% |
| 2023 Q3 | 151.18 Million HKD | 208.28% |
| 2023 Q1 | 182.41 Million HKD | 208.37% |
| 2023 FY | -175.44 Million HKD | -4.23% |
| 2023 Q2 | -139.62 Million HKD | -176.54% |
| 2023 Q4 | -175.44 Million HKD | -216.04% |
| 2022 Q2 | -96.88 Million HKD | -161.77% |
| 2022 Q1 | 156.85 Million HKD | 225.72% |
| 2022 FY | -168.32 Million HKD | -34.91% |
| 2022 Q4 | -168.32 Million HKD | -227.11% |
| 2022 Q3 | 132.42 Million HKD | 236.68% |
| 2021 Q2 | -118.52 Million HKD | -196.7% |
| 2021 Q1 | 122.56 Million HKD | 222.19% |
| 2021 FY | -124.76 Million HKD | -24.37% |
| 2021 Q4 | -124.76 Million HKD | 0.0% |
| 2020 FY | -100.31 Million HKD | -3.83% |
| 2020 Q4 | -100.31 Million HKD | 0.0% |
| 2020 Q1 | 114.24 Million HKD | 218.25% |
| 2020 Q2 | -92.12 Million HKD | -180.64% |
| 2019 Q2 | -80.23 Million HKD | -177.42% |
| 2019 Q1 | 103.62 Million HKD | 200.0% |
| 2019 Q4 | -96.6 Million HKD | 0.0% |
| 2019 FY | -96.6 Million HKD | 6.77% |
| 2018 Q4 | -103.62 Million HKD | 0.0% |
| 2018 FY | -103.62 Million HKD | -7.48% |
| 2018 Q2 | -83.86 Million HKD | -185.81% |
| 2018 Q1 | 97.73 Million HKD | 201.37% |
| 2017 Q1 | -31.59 Million HKD | 7.34% |
| 2017 Q4 | -96.41 Million HKD | 0.0% |
| 2017 FY | -96.41 Million HKD | -182.78% |
| 2016 Q4 | -34.09 Million HKD | 0.0% |
| 2016 FY | -34.09 Million HKD | -3413.31% |
| 2015 FY | 1.02 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 27.54 Million HKD | 736.945% |
| Innovative Pharmaceutical Biotech Limited | 914.37 Million HKD | 119.187% |
| China Overseas Nuoxin International Holdings Limited | 9.99 Million HKD | 1855.98% |
| Prosperous Future Holdings Limited | -337.41 Million HKD | 48.005% |
| Huasheng International Holding Limited | 175.03 Million HKD | 200.23% |
| Fourace Industries Group Holdings Limited | -250.33 Million HKD | 29.917% |
| Evergreen Products Group Limited | 430.83 Million HKD | 140.721% |
| EC Healthcare | 1.05 Billion HKD | 116.707% |
| Ming Fai International Holdings Limited | -329.49 Million HKD | 46.754% |
| Blue Moon Group Holdings Limited | -4.18 Billion HKD | 95.807% |
| SuperRobotics Holdings Limited | 126.44 Million HKD | 238.752% |
| Hyfusin Group Holdings Limited | -318.4 Million HKD | 44.901% |